Regulatory
Shipment Delays for Sanofi’s Pompe Disease Drug Rattle Patients
Reported delays in delivering Nexviazyme — an enzyme therapy for a rare, progressive disease — follow an FDA warning letter over a Sanofi manufacturing site.